^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Triple Negative Breast Cancer |
| Drug: | carboplatin (Tubulin polymerization promoter) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
Published date:
01/28/2021
Excerpt:
Carboplatin may be offered as part of a neoadjuvant regimen in patients with TNBC to increase likelihood of pCR.
DOI:
10.1200/JCO.20. 03399
